Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2024 Earnings Call Transcript October 31, 2024
Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.27, expectations were $0.98.
Operator: Good afternoon. My name is Jal [ph] and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Halozyme Third Quarter 2024 Financial and Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the...
